{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T10:34:54Z","timestamp":1787481294054,"version":"build-2736575974"},"reference-count":156,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The pathetic malignant mesothelioma (MM) is a extremely uncommon and confrontational tumor that evolves in the mesothelium layer of the pleural cavities (inner lining- visceral pleura and outer lining- parietal pleura), peritoneum, pericardium, and tunica vaginalis and is highly resistant to standard treatments. In mesothelioma, the predominant pattern of lesions is a loss of genes that limit tumour growth. Despite the worldwide ban on the manufacture and supply of asbestos, the prevalence of mesothelioma continues to increase. Mesothelioma presents and behaves in a variety of ways, making diagnosis challenging. Most treatments available today for MM are ineffective, and the median life expectancy is between 10 and 12 months. However, in recent years, considerable progress has already been made in understanding the genetics and molecular pathophysiology of mesothelioma by addressing hippo signaling pathway. The development and progression of MM are related to many important genetic alterations. This is related to NF2 and\/or LATS2 mutations that activate the transcriptional coactivator YAP. The X-rays, CT scans, MRIs, and PET scans are used to diagnose the MM. The MM are treated with surgery, chemotherapy, first-line combination chemotherapy, second-line treatment, radiation therapy, adoptive T-cell treatment, targeted therapy, and cancer vaccines. Recent clinical trials investigating the function of surgery have led to the development of innovative approaches to the treatment of associated pleural effusions as well as the introduction of targeted medications. An interdisciplinary collaborative approach is needed for the effective care of persons who have mesothelioma because of the rising intricacy of mesothelioma treatment. This article highlights the key findings in the molecular pathogenesis of mesothelioma, diagnosis with special emphasis on the management of mesothelioma.<\/jats:p>","DOI":"10.3389\/fonc.2023.1204722","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T17:17:06Z","timestamp":1688491026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies"],"prefix":"10.3389","volume":"13","author":[{"given":"Ram Kumar","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakina","family":"Ruhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Jeppu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husni Ahmed","family":"Al-Goshae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Nagdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retno","family":"Widyowati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiwied","family":"Ekasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyauddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedanta","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankha","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra K.","family":"Jangde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/cancers15030662","article-title":"Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma","volume":"15","author":"Kusamura","year":"2023","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-19-2852-9_7","article-title":"Application of agricultural waste in anionic dyes removal from wastewater","volume-title":"Textile wastewater treatment: sustainable bio-nano materials and macromolecules","author":"Chinedu Egbosiuba","year":"2022"},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","article-title":"EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach","volume":"15","author":"Nicholson","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0226-2020","article-title":"Update on biology and management of mesothelioma","volume":"30","author":"Asciak","year":"2021","journal-title":"Eur Respir Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000936","article-title":"Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease","volume":"29","author":"Joshi","year":"2023","journal-title":"Curr Opin Pulmonary Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/19338244.2021.1873095","article-title":"Anthophyllite asbestos from Staten island, new York: longitudinal fiber splitting","volume":"77","author":"Germine","year":"2022","journal-title":"Arch Environ Occup Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.03.014","article-title":"Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations","volume":"7","author":"Carbone","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"33","author":"Popat","year":"2022","journal-title":"Ann Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29060340","article-title":"Extra-pleural pneumonectomy (EPP) in children and adults with locally advanced sarcoma: a CanSaRCC study","volume":"29","author":"Rodrigues","year":"2022","journal-title":"Curr Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1466","article-title":"FDA Approval summary: nivolumab in combination with ipilimumab for the treatment of unresectable malignant pleural MesotheliomaNivolumab and ipilimumab for malignant pleural mesothelioma","volume":"28","author":"Nakajima","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01462-2","article-title":"Biological basis for novel mesothelioma therapies","volume":"125","author":"Obacz","year":"2021","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/biomedicines10071704","article-title":"Forced overexpression of signal transducer and activator of transcription 3 (STAT3) activates yes-associated protein (YAP) expression and increases the invasion and proliferation abilities of small cell lung cancer (SCLC) cells","volume":"10","author":"Hsu","year":"2022","journal-title":"Biomedicines"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40164-022-00356-0","article-title":"New insights into epigenetic regulation of resistance to PD-1\/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities","volume":"11","author":"Dai","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"300705","DOI":"10.1016\/j.hpr.2023.300705","article-title":"Identification of identical BAP1 mutations in a patient\u2019s peritoneal mesothelioma and mucosal melanoma: a precision medicine case study","volume":"32","author":"Zamiara","year":"2023","journal-title":"Hum Pathol Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-023-01505-0","article-title":"Mutational signature of extracranial meningioma metastases and their respective primary tumors","volume":"11","author":"Biczok","year":"2023","journal-title":"Acta Neuropathologica Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2183\/pjab.99.003","article-title":"Medical application of the monoclonal antibody SKM9-2 against sialylated HEG1, a new precision marker for malignant mesothelioma","volume":"99","author":"Tsuji","year":"2023","journal-title":"Proc Japan Academy Ser B"},{"key":"B17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/ijms22020690","article-title":"Neurofibromatosis type 2 (NF2) and the implications for vestibular schwannoma and meningioma pathogenesis","volume":"22","author":"Bachir","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.3390\/molecules27196247","article-title":"Inhibition of MORC2 mediates HDAC4 to promote cellular senescence through p53\/p21 signaling axis","volume":"27","author":"Ou","year":"2022","journal-title":"Molecules"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-0083","article-title":"Mesothelioma biomarkers: a review highlighting contributions from the early detection research NetworkMesothelioma biomarkers and EDRN","volume":"29","author":"Pass","year":"2020","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.3390\/su14095286","article-title":"Searching for sustainability in health systems: toward a multidisciplinary evaluation of mobile health innovations","volume":"14","author":"Degavre","year":"2022","journal-title":"Sustainability"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100430","DOI":"10.1016\/j.jtocrr.2022.100430","article-title":"Viral mimicry response is associated with clinical outcome in pleural mesothelioma","volume":"3","author":"Sun","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000527971","article-title":"Asbestos exposure and malignant pleural mesothelioma: a systematic review of literature","volume":"40","author":"Santos","year":"2022","journal-title":"Portuguese J Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-022-02582-2","article-title":"MiR-129-5p exerts wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF","volume":"22","author":"Huge","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41420-023-01307-2","article-title":"MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death Discovery"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.811434","article-title":"The impact of hyaluronan on tumor progression in cutaneous melanoma","volume":"11","author":"Takabe","year":"2022","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12995-023-00367-5","article-title":"Exposure to cosmetic talc and mesothelioma","volume":"18","author":"Moline","year":"2023","journal-title":"J Occup Med Toxicol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019652117","article-title":"Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma","volume":"117","author":"Bononi","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/ijms23063225","article-title":"Repositioning the role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on the TRAIL to the development of diabetes mellitus: an update of experimental and clinical evidence","volume":"23","author":"Koliaki","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2023.008","article-title":"Current causes of mesothelioma: how has the asbestos ban changed the perspective","volume":"167","author":"Janosikova","year":"2023","journal-title":"Biomed Papers."},{"key":"B30","first-page":"1","article-title":"Antioxidant in cancer: preventer, promoter or an Achilles heel","volume-title":"Handbook of oxidative stress in cancer: therapeutic aspects","author":"Wahabi","year":"2022"},{"key":"B31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/cncy.22509","article-title":"Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology","volume":"130","author":"Girolami","year":"2022","journal-title":"Cancer cytopathology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.24922","article-title":"Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: a systematic review","volume":"27","author":"de Morais","year":"2022","journal-title":"Medicina Oral Patolog\u00eda Oral y Cirug\u00eda Bucal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/cancers12051186","article-title":"Malignant pleural mesothelioma: genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge","volume":"12","author":"Abbott","year":"2020","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01082-y","article-title":"Well differentiated papillary mesothelial tumor: a new name and new problems","volume":"35","author":"Churg","year":"2022","journal-title":"Modern Pathol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/cells11050849","article-title":"High mobility group box 1: biological functions and relevance in oxidative stress related chronic diseases","volume":"11","author":"Taverna","year":"2022","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41021-023-00258-5","article-title":"Environmental impact on carcinogenesis under BRCA1 haploinsufficiency","volume":"45","author":"Toyokuni","year":"2023","journal-title":"Genes Environ"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/maq.12587","article-title":"The WetNet: what the oral polio vaccine hypothesis exposes about globalized interspecies fluid bonds","volume":"34","author":"Jain","year":"2020","journal-title":"Med Anthropology Q"},{"key":"B38","doi-asserted-by":"publisher","first-page":"a036129","DOI":"10.1101\/cshperspect.a036129","article-title":"Discovery of the PTEN tumor suppressor and its connection to the PI3K and AKT oncogenes","volume":"10","author":"Parsons","year":"2020","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4103\/ijmr.IJMR_1_20","article-title":"Malignant pleural mesothelioma: a guide for clinicians","volume":"153","author":"Siddaraju","year":"2021","journal-title":"Indian J Med Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cells11081370","article-title":"Genomic hippo pathway alterations and persistent YAP\/TAZ activation: new hallmarks in head and neck cancer","volume":"11","author":"Faraji","year":"2022","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-022-02394-2","article-title":"The hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease","volume":"41","author":"Cigliano","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3390\/cancers14133108","article-title":"Mesothelioma mouse models with mixed genomic states of chromosome and microsatellite instability","volume":"14","author":"Song","year":"2022","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119201","article-title":"Regulation of hippo signaling by metabolic pathways in cancer","volume":"119201","author":"Lee","year":"2022","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-021-2018-7","article-title":"REG\u03b3 drives Lgr5+ stem cells to potentiate radiation induced intestinal regeneration","volume":"65","author":"Zhu","year":"2022","journal-title":"Sci China Life Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8346","article-title":"miRNAs and the hippo pathway in cancer: exploring the therapeutic potential","volume":"48","author":"Arora","year":"2022","journal-title":"Oncol Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-022-00900-2","article-title":"Molecular alterations in malignant pleural mesothelioma: a hope for effective treatment by targeting YAP","volume":"17","author":"Dubois","year":"2022","journal-title":"Targeted Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/gad.350127.122","article-title":"YAP\u2013VGLL4 antagonism defines the major physiological function of the hippo signaling effector YAP","volume":"36","author":"Cai","year":"2022","journal-title":"Genes Dev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cancers10040090","article-title":"Targeting the hippo pathway is a new potential therapeutic modality for malignant mesothelioma","volume":"10","author":"Sekido","year":"2018","journal-title":"Cancers"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2021.04.001","article-title":"Fiber burden and asbestos-related diseases: an umbrella review","volume":"36","author":"Ramada Rodilla","year":"2022","journal-title":"Gaceta sanitaria"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.130077","article-title":"Journey to the centre of the lung. the perspective of a mineralogist on the carcinogenic effects of mineral fibres in the lungs","volume":"130077","author":"Gualtieri","year":"2022","journal-title":"J Hazard Mater"},{"key":"B51","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.comtox.2022.100233","article-title":"Discriminant analysis of asbestiform and non-asbestiform amphibole particles and its implications for toxicological studies","volume":"23","author":"Wylie","year":"2022","journal-title":"Comput Toxicol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.26493\/1854-6935.20.259-293","article-title":"Sustainability and sustainable development research around the world","volume":"20","author":"Ozili","year":"2022","journal-title":"Manag Global Trans."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-022-02168-y","article-title":"What has changed in malignant mesothelioma between 1990 and 2019? a time-series analyses in Turkey","volume":"27","author":"Metintas","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.15585\/mmwr.mm7119a1","article-title":"Malignant mesothelioma mortality in women\u2013united states 1999\u20132020","volume":"71","author":"Mazurek","year":"2022","journal-title":"Morbidity Mortality Weekly Rep"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.4028\/p-hz8h6t","article-title":"The problem of asbestos-cement sheets disposal in the k\u0142obuck poviat","author":"Brycht","year":"2022"},{"key":"B56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/08897077.2021.1913696","article-title":"Trends in binge drinking, marijuana use, illicit drug use, and polysubstance use by sexual identity in the united states, (2006\u20132017)","volume":"43","author":"McCabe","year":"2022","journal-title":"Subst Abuse"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20220064","article-title":"Mesothelioma in a developing country: a retrospective analysis of the diagnostic process","volume":"48","author":"Greg\u00f3rio","year":"2022","journal-title":"Jornal Brasileiro Pneumologia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/26339447221136370","article-title":"Sodium valproate-induced eosinophilic exudative pleural effusion","author":"Mohammed","year":"2022","journal-title":"Indian J Clin Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1016\/j.jorep.2022.100121","article-title":"Thoracic duct injury after AO c thoracic spine fracture: a case report","volume":"2","author":"Curtin","year":"2023","journal-title":"J Orthopaedic Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.07.001","article-title":"The staging of malignant pleural mesothelioma","volume":"30","author":"Euhus","year":"2020","journal-title":"Thorac Surg Clinics"},{"key":"B61","article-title":"Sinonasal inverted papilloma: etiology, pathogenesis, and clinical characteristics","author":"Viitasalo","year":"2023","journal-title":"Dissertationes scholae doctoralis ad sanitatem investigandam Universitatis Helsinkiensis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/life13010115","article-title":"Malignant pleural effusions: updates in diagnosis and management","volume":"13","author":"Hughes","year":"2023","journal-title":"Life"},{"key":"B63","article-title":"Microvascular decompression for cranial nerve disorders","volume-title":"Koht, Sloan, toleikis's monitoring the nervous system for anesthesiologists and other health care professionals","author":"Shandal","year":"2022"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26113","article-title":"Impact of sleep-disordered breathing on the management of children with chiari malformation type I","volume":"57","author":"Vagianou","year":"2022","journal-title":"Pediatr Pulmonology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"106802","DOI":"10.1016\/j.rmed.2022.106802","article-title":"Update on the diagnosis and management of malignant pleural effusions","volume":"196","author":"Bashour","year":"2022","journal-title":"Respir Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0250-2021","article-title":"Understanding the pathogenesis of occupational coal and silica dust-associated lung disease","volume":"31","author":"Vanka","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/cancers13112798","article-title":"Diving into the pleural fluid: liquid biopsy for metastatic malignant pleural effusions","volume":"13","author":"Sorolla","year":"2021","journal-title":"Cancers"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001672","article-title":"Asbestos and ovarian cancer: examining the historical evidence","volume":"31","author":"Slomovitz","year":"2021","journal-title":"Int J Gynecologic Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5353","article-title":"Utility of BerEp4\/calretinin and desmin\/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology","volume":"12","author":"Hjerpe","year":"2022","journal-title":"Cancer Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2022.06.014","article-title":"Assessment of clinical guidelines for medication-related osteonecrosis of the jaw: current status and future directions","volume":"134","author":"Barrette","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202107-810RL","article-title":"Cell-free DNA concentration and pattern fragmentation in pleural fluid and plasma to detect malignant effusions","volume":"19","author":"Porcel","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11383","article-title":"Differentiating malignant pleural mesothelioma and metastatic pleural disease based on a machine learning model with primary CT signs: a multicentre study","volume":"8","author":"Li","year":"2022","journal-title":"Heliyon"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3390\/cancers14133179","article-title":"Prospective comparison of the performance of MRI versus CT in the detection and evaluation of peritoneal surface malignancies","volume":"14","author":"Chia","year":"2022","journal-title":"Cancers"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/jbi\/wbab027","article-title":"Contrast-enhanced mammography: a guide to setting up a new clinical program","volume":"3","author":"Kim","year":"2021","journal-title":"J Breast Imaging"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.08.113","article-title":"Diagnostic laparoscopy improves staging of malignant pleural mesothelioma with routine positron emission tomography imaging","volume":"112","author":"Ripley","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.10.001","article-title":"Overview and recent advances in 18F-FDG PET\/CT for evaluation of pediatric lymphoma","volume":"53","author":"Guja","year":"2022","journal-title":"Semin Nucl Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.01.002","article-title":"Commentary: assessing tumor stage and treatment response in pleural mesothelioma: are pleural thickness measurements the new standard","author":"Rusch","year":"2023","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2022.2085090","article-title":"Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis","volume":"16","author":"Song","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43055-023-00978-2","article-title":"Extra-pleural space on CT: common lesions and diagnostic approach","volume":"54","author":"Sabri","year":"2023","journal-title":"Egyptian J Radiol Nucl Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.adro.2022.101143","article-title":"Preliminary analysis of a phase II trial of stereotactic body radiation therapy for prostate cancer with high-risk features after radical prostatectomy","volume":"8","author":"Laughlin","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.3390\/cancers14204988","article-title":"A retrospective, single-center analysis of specialized palliative care services for patients with advanced small-cell lung cancer","volume":"14","author":"Wachter","year":"2022","journal-title":"Cancers"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2021.08.003","article-title":"Treatment patterns and outcomes of patients with advanced pleural mesothelioma at an academic referral centre","volume":"23","author":"Schmid","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000551","article-title":"Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol","volume":"7","author":"Hoon","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.5935\/2177-1235.2021RBCP0100","article-title":"Multicystic epithelioid mesothelioma infiltrating abdominal wall and thigh: case report","volume":"36","author":"Fontinele","year":"2022","journal-title":"Rev Bras Cirurgia Pl\u00e1stica"},{"key":"B85","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.suc.2020.02.009","article-title":"Peritoneal cancers and hyperthermic intraperitoneal chemotherapy","volume":"100","author":"Pletcher","year":"2020","journal-title":"Surg Clinics"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2021.08.063","article-title":"Postoperative empyema after pleurectomy decortication for malignant pleural mesothelioma","volume":"114","author":"Lapidot","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"107280","DOI":"10.1016\/j.cmpb.2022.107280","article-title":"Reinforcement learning strategies in cancer chemotherapy treatment: a review","volume":"229","author":"Yang","year":"2022","journal-title":"Comput Methods Prog Biomed"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032109","article-title":"Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: a case report","volume":"101","author":"Tao","year":"2022","journal-title":"Medicine"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7233559","article-title":"Comparison efficacy and safety of gemcitabine plus cisplatin and 5-fluorouracil plus cisplatin for metastatic nasopharyngeal carcinoma: a meta-analysis and systematic review","volume":"2022","author":"Yan","year":"2022","journal-title":"J Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.02.010","article-title":"New agents in the management of advanced mesothelioma","volume":"32","author":"Vogelzang","year":"2005","journal-title":"Semin Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cllc.2022.10.002","article-title":"Regression of malignant pleural mesothelioma in absence of chemotherapy or surgery: a case series","volume":"24","author":"Nief","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e221490","DOI":"10.1001\/jamanetworkopen.2022.1490","article-title":"Comparison of 3 randomized clinical trials of frontline therapies for malignant pleural mesothelioma","volume":"5","author":"Meirson","year":"2022","journal-title":"JAMA Network Open"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.858557","article-title":"How our continuing studies of the pre-clinical inbred mouse models of mesothelioma have influenced the development of new therapies","volume":"13","author":"Robinson","year":"2022","journal-title":"Front Pharmacol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.03.030","article-title":"The use of radiation therapy for the treatment of malignant pleural mesothelioma: expert opinion from the national cancer institute thoracic malignancy steering committee, international association for the study of lung cancer, and mesothelioma applied research foundation","volume":"14","author":"Gomez","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00105","article-title":"Manipulating microRNAs for the treatment of malignant pleural mesothelioma: past, present and future","volume":"10","author":"Reid","year":"2020","journal-title":"Front Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4102","article-title":"First-ever abscopal effect after palliative radiotherapy and immuno-gene therapy for malignant pleural mesothelioma","volume":"11","author":"Barsky","year":"2019","journal-title":"Cureus"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15660","article-title":"Limited toxicity of hypofractionated intensity modulated radiation therapy for head and neck cancer","volume":"42","author":"Mayo","year":"2022","journal-title":"Anticancer Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00126","article-title":"Antiangiogeneic strategies in mesothelioma","volume":"10","author":"Nowak","year":"2020","journal-title":"Front Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00538-9","article-title":"The expanding role for small molecules in immuno-oncology","volume":"21","author":"Offringa","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.03.014","article-title":"Prognostic impact of inflammation in malignant pleural mesothelioma: a large-scale analysis of consecutive patients","volume":"166","author":"Fournel","year":"2022","journal-title":"Lung Cancer"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.02.022","article-title":"Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling","volume":"86","author":"Jha","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10143-019-01203-3","article-title":"Recent progress in the research of suicide gene therapy for malignant glioma","volume":"44","author":"Tamura","year":"2021","journal-title":"Neurosurgical Rev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.2147\/OTT.S227156","article-title":"Circulating cell-free DNA or circulating tumor DNA in the management of ovarian and endometrial cancer","volume":"12","author":"Chen","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B104","first-page":"114","article-title":"How close are miRNAs from clinical practice? a perspective on the diagnostic and therapeutic market","volume":"30","author":"Bonneau","year":"2019","journal-title":"Ejifcc"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/pharmaceutics14102027","article-title":"Applications of exosomes in diagnosing muscle invasive bladder cancer","volume":"14","author":"Walker","year":"2022","journal-title":"Pharmaceutics"},{"key":"B106","doi-asserted-by":"publisher","first-page":"114037","DOI":"10.1016\/j.ejmech.2021.114037","article-title":"A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy","volume":"228","author":"Li","year":"2022","journal-title":"Eur J Medicinal Chem"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol Cancer"},{"key":"B108","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/cancers15010125","article-title":"Serum extracellular vesicle-derived microRNAs as potential biomarkers for pleural mesothelioma in a European prospective study","volume":"15","author":"Casalone","year":"2023","journal-title":"Cancers"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34339","article-title":"Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: the EPIC prospective cohort","volume":"152","author":"Allione","year":"2023","journal-title":"Int J Cancer"},{"key":"B110","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/diagnostics12020311","article-title":"Big and free fractions of gamma-glutamyltransferase: new diagnostic biomarkers for malignant mesothelioma","volume":"12","author":"Foddis","year":"2022","journal-title":"Diagnostics"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/br.2022.1549","article-title":"Clinical significance of 9P21 gene combined with BAP1 and MTAP protein expression in diagnosis and prognosis of mesothelioma serous effusion","volume":"17","author":"Ma","year":"2022","journal-title":"Biomed Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.953283","article-title":"The role of osteopontin in tumor progression through tumor-associated macrophages","volume":"12","author":"Tan","year":"2022","journal-title":"Front Oncol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-023-05888-z","article-title":"Urine biomarker score captures response to induction therapy with lupus nephritis","author":"Cody","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1014749","article-title":"The extracellular matrix protein fibulin-3\/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K\/Akt signaling","volume":"12","author":"Roshini","year":"2022","journal-title":"Front Oncol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.21037\/tcr-22-2873","article-title":"Serum diagnostic markers for malignant pleural mesothelioma: a narrative review","volume":"11","author":"Wang","year":"2022","journal-title":"Trans Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"107152","DOI":"10.1016\/j.anireprosci.2022.107152","article-title":"High mobility group box-1 regulates expression of EGFR, VEGF, StAR and TIMP1\/2 in bovine granulosa cells through a mechanism involving TLR2\/NF-\u03baB","volume":"247","author":"Xie","year":"2022","journal-title":"Anim Reprod Sci"},{"key":"B117","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.104448","article-title":"Fibulin-3 as a biomarker of pleuric involvement by exposure to fibers","volume-title":"Mesothelioma-diagnostics, treatment and basic research","author":"Rapisarda","year":"2022"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30125","article-title":"HMGB1 as a therapeutic target in disease","volume":"236","author":"Xue","year":"2021","journal-title":"J Cell Physiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1159\/000458736","article-title":"Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B120","volume-title":"Bibliographic review-fondazione buzzi","author":"Auditor","year":"2022"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/cancers12061566","article-title":"Circulating tumor DNA as a novel biomarker optimizing chemotherapy for colorectal cancer","volume":"12","author":"Osumi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02624-1","article-title":"Heparanase and the hallmarks of cancer","volume":"18","author":"Jayatilleke","year":"2020","journal-title":"J Trans Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","article-title":"Heparanase: from basic research to therapeutic applications in cancer and inflammation","volume":"29","author":"Vlodavsky","year":"2016","journal-title":"Drug Resistance Updates"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy032","article-title":"Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications","volume":"110","author":"Barash","year":"2018","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B125","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11658-018-0078-0","article-title":"STAT3, stem cells, cancer stem cells and p63","volume":"23","author":"Galoczova","year":"2018","journal-title":"Cell Mol Biol Lett"},{"key":"B126","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","article-title":"JAK-STAT signaling in cancer: from cytokines to non-coding genome","volume":"87","author":"Pencik","year":"2016","journal-title":"Cytokine"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006839","article-title":"Viral manipulation of STAT3: evade, exploit, and injure","volume":"14","author":"Roca Suarez","year":"2018","journal-title":"PloS Pathog"},{"key":"B128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/cancers13010007","article-title":"Inhibitors of the transcription factor STAT3 decrease growth and induce immune response genes in models of malignant pleural mesothelioma (MPM)","volume":"13","author":"Lapidot","year":"2020","journal-title":"Cancers"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.16.00030","article-title":"Programmed cell death 1 (PD-1) ligand (PD-L1) expression in solid tumors as a predictive biomarker of benefit from PD-1\/PD-L1 axis inhibitors: a systematic review and meta-analysis","volume":"1","author":"Khunger","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cancers9090115","article-title":"Chimeric antigen receptor (CAR) T cell therapy for malignant pleural mesothelioma (MPM)","volume":"9","author":"Klampatsa","year":"2017","journal-title":"Cancers"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0170","article-title":"Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid MalignanciesCase report: RNA CAR T cells","volume":"2","author":"Beatty","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B132","doi-asserted-by":"publisher","first-page":"261ra151","DOI":"10.1126\/scitranslmed.3010162","article-title":"Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity","volume":"6","author":"Adusumilli","year":"2014","journal-title":"Sci Trans Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/EDBK_156572","article-title":"Basic overview of current immunotherapy approaches in cancer","volume":"36","author":"Velcheti","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3184","article-title":"International consensus definition of DNA methylation subgroups in juvenile myelomonocytic LeukemiaDNA methylation subgroups in JMML","volume":"27","author":"Sch\u00f6nung","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/tlcr.2019.05.05","article-title":"A multicenter, randomized, phase II\/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell immunotherapy for mesothelioma (DENIM) trial","volume":"8","author":"Belderbos","year":"2019","journal-title":"Trans Lung Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00649-7","article-title":"Immunotherapy approaches for malignant pleural mesothelioma","volume":"19","author":"Fennell","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/imr.12525","article-title":"Immunoregulatory functions of VISTA","volume":"276","author":"Nowak","year":"2017","journal-title":"Immunol Rev"},{"key":"B138","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/cancers11050628","article-title":"Beyond PD-1\/PD-L1 inhibition: what the future holds for breast cancer immunotherapy","volume":"11","author":"Chr\u00e9tien","year":"2019","journal-title":"Cancers"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2018_180610N385","article-title":"Immunoregulation effects of TIM-3 on tumors","volume":"66","author":"Sheng","year":"2019","journal-title":"Neoplasma"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32363","article-title":"NK-and T-cell subsets in malignant mesothelioma patients: baseline pattern and changes in the context of anti-CTLA-4 therapy","volume":"145","author":"Sottile","year":"2019","journal-title":"Int J Cancer"},{"key":"B141","doi-asserted-by":"publisher","first-page":"89722","DOI":"10.18632\/oncotarget.21113","article-title":"Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients","volume":"8","author":"Marcq","year":"2017","journal-title":"Oncotarget"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1494111","article-title":"Combination immune checkpoint blockade as an effective therapy for mesothelioma","volume":"7","author":"Fear","year":"2018","journal-title":"Oncoimmunology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.14744\/ejmi.2022.38653","article-title":"A laboratory prognostic index model for predicting survival in patients with malignant pleural mesothelioma","volume":"6","author":"Basoglu","year":"2022","journal-title":"Eur J Med Investig"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.559586","article-title":"Calcitriol inhibits viability and proliferation in human malignant pleural mesothelioma cells","volume":"11","author":"Gesmundo","year":"2020","journal-title":"Front Endocrinol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.01.012","article-title":"Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-schlafen 11 and low-O6-methylguanine-DNA methyltransferase expression","volume":"15","author":"Rathkey","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.03.172","article-title":"HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells","volume":"526","author":"Fujii","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/cancers12082285","article-title":"YB-1 knockdown inhibits the proliferation of mesothelioma cells through multiple mechanisms","volume":"12","author":"Johnson","year":"2020","journal-title":"Cancers"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2020.5075","article-title":"Biomarkers of tumor invasiveness in proteomics","volume":"57","author":"Pouliquen","year":"2020","journal-title":"Int J Oncol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/his.14916","article-title":"High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma","author":"Chu","year":"2023","journal-title":"Histopathology."},{"key":"B150","doi-asserted-by":"publisher","first-page":"220174","DOI":"10.1183\/16000617.0174-2022","article-title":"Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours","volume":"32","author":"Dumoulin","year":"2023","journal-title":"Eur Respir Rev"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/jcm12051757","article-title":"The evolving role of immune-checkpoint inhibitors in malignant pleural mesothelioma","volume":"12","author":"Borgeaud","year":"2023","journal-title":"J Clin Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01321-1","article-title":"Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity","volume":"5","author":"Mangiante","year":"2023","journal-title":"Nat Genet"},{"key":"B153","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.3390\/ijms24076689","article-title":"A selective ALDH1A3 inhibitor impairs mesothelioma 3-d multicellular spheroid growth and neutrophil recruitment","volume":"24","author":"Boumya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-22-0635","article-title":"BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification","volume":"21","author":"Barnett","year":"2023","journal-title":"Mol Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43440-023-00480-6","article-title":"A role for macrophages under cytokine control in mediating resistance to ADI PEG20 (pegargiminase) in ASS1-deficient mesothelioma","author":"Phillips","year":"2023","journal-title":"Pharmacol Rep"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/cancers15051357","article-title":"Challenges of anti-mesothelin CAR-T-Cell therapy","volume":"15","author":"Zhai","year":"2023","journal-title":"Cancers"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1204722\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T17:17:15Z","timestamp":1688491035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1204722\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":156,"alternative-id":["10.3389\/fonc.2023.1204722"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1204722","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"article-number":"1204722"}}